Patient characteristics and Notch1 immunohistochemical stain scores
| Patient no. . | Age, y . | Sex . | Diagnosis . | Stage . | Notch status in tumor cells . |
|---|---|---|---|---|---|
| 1 | 75 | Female | MF patch | IB | Negative |
| 2 | 44 | Female | MF patch | IB | Negative |
| 3 | 67 | Male | MF patch | IB | Negative |
| 4 | 59 | Male | MF patch | IB | Negative |
| 5 | 59 | Male | MF patch | IB | Negative |
| 6 | 55 | Female | MF patch | IB | > 50% |
| 7 | 44 | Female | MF plaque | I | Negative |
| 8 | 57 | Male | MF plaque | IB | Negative |
| 9 | 80 | Female | MF plaque | I | Negative |
| 10 | 77 | Male | MF erythrodermic | IIIA | Negative |
| 11 | 80 | Male | MF plaque | IB | Negative |
| 12 | 49 | Female | MF plaque | IB | Negative |
| 13 | 33 | Male | MF plaque | IA | Negative |
| 14 | 56 | Male | MF plaque | I | > 10% - < 50% |
| 15 | 44 | Male | MF folliculotropic | IB | > 10% - < 50% |
| 16 | 33 | Male | MF plaque | IA | > 50% |
| 17 | 74 | Female | MF tumor | IIB | Negative |
| 18 | 84 | Female | MF tumor | IIB | > 50% |
| 19 | 50 | Female | MF tumor | IVB | > 50% |
| 20 | 70 | Female | MF tumor | IIB | > 50% |
| 21 | 82 | Male | MF tumor | IIB | > 50% |
| 22 | 66 | Male | MF tumor | IIB | > 50% |
| 23 | 57 | Female | MF tumor | IIB | > 50% |
| 24 | 79 | Male | MF tumor | IIB | > 50% |
| 25 | 58 | Male | MF tumor | IIB | > 50% |
| 26 | 84 | Female | MF transformed | IIB | Negative |
| 27 | 83 | Male | MF transformed | IIB | Negative |
| 28 | 71 | Male | MF transformed | IIB | Negative |
| 29 | 77 | Male | MF transformed | II | > 10% - < 50% |
| 30 | 63 | Male | MF transformed | IIB | > 10% - < 50% |
| 31 | 57 | Male | MF transformed | IVB | > 10% - < 50% |
| 32 | 51 | Female | MF transformed | IVB | > 10% - < 50% (same patient as patient 19) |
| 33 | 61 | Female | MF transformed | IVA | > 50% |
| 34 | 67 | Male | MF transformed | IIA | > 50% |
| 35 | 77 | Male | MF transformed | IVA | > 50% |
| 36 | 68 | Male | SS | IVA | Negative |
| 37 | 71 | Male | SS | IVB | Negative |
| 38 | 72 | Male | SS | IVA | Negative |
| 39 | 73 | Male | SS | IVB | > 50% |
| 40 | 65 | Male | SS | IV | > 50% |
| Patient no. . | Age, y . | Sex . | Diagnosis . | Stage . | Notch status in tumor cells . |
|---|---|---|---|---|---|
| 1 | 75 | Female | MF patch | IB | Negative |
| 2 | 44 | Female | MF patch | IB | Negative |
| 3 | 67 | Male | MF patch | IB | Negative |
| 4 | 59 | Male | MF patch | IB | Negative |
| 5 | 59 | Male | MF patch | IB | Negative |
| 6 | 55 | Female | MF patch | IB | > 50% |
| 7 | 44 | Female | MF plaque | I | Negative |
| 8 | 57 | Male | MF plaque | IB | Negative |
| 9 | 80 | Female | MF plaque | I | Negative |
| 10 | 77 | Male | MF erythrodermic | IIIA | Negative |
| 11 | 80 | Male | MF plaque | IB | Negative |
| 12 | 49 | Female | MF plaque | IB | Negative |
| 13 | 33 | Male | MF plaque | IA | Negative |
| 14 | 56 | Male | MF plaque | I | > 10% - < 50% |
| 15 | 44 | Male | MF folliculotropic | IB | > 10% - < 50% |
| 16 | 33 | Male | MF plaque | IA | > 50% |
| 17 | 74 | Female | MF tumor | IIB | Negative |
| 18 | 84 | Female | MF tumor | IIB | > 50% |
| 19 | 50 | Female | MF tumor | IVB | > 50% |
| 20 | 70 | Female | MF tumor | IIB | > 50% |
| 21 | 82 | Male | MF tumor | IIB | > 50% |
| 22 | 66 | Male | MF tumor | IIB | > 50% |
| 23 | 57 | Female | MF tumor | IIB | > 50% |
| 24 | 79 | Male | MF tumor | IIB | > 50% |
| 25 | 58 | Male | MF tumor | IIB | > 50% |
| 26 | 84 | Female | MF transformed | IIB | Negative |
| 27 | 83 | Male | MF transformed | IIB | Negative |
| 28 | 71 | Male | MF transformed | IIB | Negative |
| 29 | 77 | Male | MF transformed | II | > 10% - < 50% |
| 30 | 63 | Male | MF transformed | IIB | > 10% - < 50% |
| 31 | 57 | Male | MF transformed | IVB | > 10% - < 50% |
| 32 | 51 | Female | MF transformed | IVB | > 10% - < 50% (same patient as patient 19) |
| 33 | 61 | Female | MF transformed | IVA | > 50% |
| 34 | 67 | Male | MF transformed | IIA | > 50% |
| 35 | 77 | Male | MF transformed | IVA | > 50% |
| 36 | 68 | Male | SS | IVA | Negative |
| 37 | 71 | Male | SS | IVB | Negative |
| 38 | 72 | Male | SS | IVA | Negative |
| 39 | 73 | Male | SS | IVB | > 50% |
| 40 | 65 | Male | SS | IV | > 50% |
Negative indicates that < 10% of tumor cells are labeled in Notch1.